Compare ARQT & ATGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | ATGE |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.8B |
| IPO Year | N/A | N/A |
| Metric | ARQT | ATGE |
|---|---|---|
| Price | $26.99 | $95.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $25.00 | ★ $145.67 |
| AVG Volume (30 Days) | ★ 1.2M | 515.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $86.38 | $9.99 |
| Revenue Next Year | $30.29 | $6.46 |
| P/E Ratio | ★ N/A | $14.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.75 | $86.26 |
| 52 Week High | $31.77 | $156.26 |
| Indicator | ARQT | ATGE |
|---|---|---|
| Relative Strength Index (RSI) | 52.62 | 38.05 |
| Support Level | $25.50 | $90.47 |
| Resistance Level | $26.97 | $104.28 |
| Average True Range (ATR) | 0.98 | 5.71 |
| MACD | 0.14 | -1.34 |
| Stochastic Oscillator | 82.37 | 19.26 |
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.